Oxford PharmaGenesis staff gathered at group headquarters in Oxford this week for the company’s annual summer party.

The need for an integrated, multidisciplinary approach to drug development, healthcare policy and decision-making was a recurring theme of the Westminster Business Forum Keynote Seminar on UK health life sciences, attended by Oxford PharmaGenesis this week in Whitehall, London, UK. This strongly supports the HealthScience concept developed by Oxford PharmaGenesis, which combines the clinical and…

A pioneering systematic methodology to identify observational data sources for specific needs has been presented by Oxford PharmaGenesis today at ISPOR’s 19th Annual International Meeting in Montreal, Canada.

A pioneering method to identify and recommend bespoke data sources for global programmes of real-world evidence is being presented at ISPOR’s 19th Annual International Meeting in Montreal, Canada (31 May–4 June 2014).

Oxford PharmaGenesis™ will be showcasing its new HealthScience approach to demonstrating product value and achieving market access at ISPOR’s 19th Annual International Meeting in Montreal, Canada (31 May–4 June 2014).

Oxford PharmaGenesis Value Demonstration Practice is proud to be an exhibitor once again at this year’s ISPOR International Meeting in Montreal, Canada.